Abstract
The purpose of this study is to investigate whether an oxygen/ozone (O2/O3) mixture protects the heart from acute myocardial infarction through local involvement of endothelial nitric oxide synthase (eNOS) and endothelial progenitor cells (EPCs). Male Sprague–Dawley rats were subject to 25-min occlusion and 2-h reperfusion of the left descending coronary artery. O2/O3 mixture was insufflated i.p. 30 min prior to ischemia/reperfusion (I/R) procedure at doses of 100, 150, and 300 μg/kg. Myocardial infarct size (IS) measurement and myocardial immunohistochemistry for EPCs were done. For these latter cells, immunoreactivities for CD34, and CD117/c-kit were assessed within the infarcted tissue. Moreover, cardiac eNOS was monitored. I/R in rats treated with O2 produced an IS as a percentage of the area at risk (IS/AR) equal to 51 ± 5%. I/R in rats treated with the O2/O3 mixture showed reduced IS (for example, IS/AR for 150 μg/kg O2/O3 was 35 ± 2.1%; P < 0.01 vs. O2). The O2/O3 cardio-protection was paralleled by an increased number of immunopositive particles per area for CD34 and CD117/c-kit. The increase of these markers was associated with an increase of cardiac eNOS expression as assayed by immunohistochemistry. Interestingly, N5-(1-Iminoethyl)-L-ornithine dihydrochloride (L-NIO), a selective eNOS activity inhibitor (30 mg/kg s.c.), prior to O2/O3 and I/R almost abolished the cardio-protection exerted by the O2/O3 mixture. L-NIO also abolished the increase in immunostaining for CD-34 and CD117/c-kit as compared with the rats receiving O2/O3 and I/R only. O2/O3 mixture protects the heart from acute myocardial infarction through local increase of eNOS expression/activity and consequent EPCs recruitment.
References
Bauersachs J, Widder JD (2008) Endothelial dysfunction in heart failure. Pharmacol Rep 60:119–126
Di Filippo C, Marfella R, Capodanno P, Ferraraccio F, Coppola L, Luongo M, Mascolo L, Luongo C, Capuano A, Rossi F, D'Amico M (2008) Acute oxygen-ozone administration to rats protects the heart from ischemia reperfusion infarct. Inflamm Res 57:445–449
Kato S, Ohkawa F, Ito Y, Amagase K, Takeuchi K (2009) Role of endothelial nitric oxide synthase in aggravation of indomethacin-induced gastric damage in adjuvant arthritic rats. J Physiol Pharmacol 60:147–155
Kocher AA, Schuster MD, Szabolcs MJ et al (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430–436
Li TS, Hamano K, Nishida M, Hayashi M, Ito H, Mikamo A, Matsuzaki M (2003) CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol 285:H931–H937
Li TS, Hayashi M, Liu ZL, Ito H, Mikamo A, Furutani A, Matsuzaki M, Hamano K (2004) Low angiogenic potency induced by the implantation of ex vivo expanded CD117(+) stem cells. Am J Physiol Heart Circ Physiol 286:H1236–H1241
Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, Klersy C, Pecci A, Moratti R, Tavazzi L (2005) Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105:199–206
Matsumura M, Fukuda N, Kobayashi N, Umezawa H, Takasaka A, Matsumoto T, Yao EH, Ueno T, Negishi N (2009) Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats. J Atheroscler Thromb 16:319–326
Rodriguez-Losada N, Garcia-Pinilla JM, Jimenez-Navarro MF, Gonzalez FJ (2008) Endothelial progenitor cells in cell-based therapy for cardiovascular disease. Cell Mol Biol (Noisy-le-grand) 54:11–23
Schuh A, Liehn EA, Sasse A, Hristov M, Sobota R, Kelm M, Merx MW, Weber C (2008) Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model. Basic Res Cardiol 103:69–77
Sekiguchi H, Ii M, Losordo DW (2009) The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J Cell Physiol 219:235–242
Acknowledgements
The authors acknowledge the surgical help of Prof Pasquale Petronella from the Second University of Naples.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Di Filippo, C., Luongo, M., Marfella, R. et al. Oxygen/ozone protects the heart from acute myocardial infarction through local increase of eNOS activity and endothelial progenitor cells recruitment. Naunyn-Schmied Arch Pharmacol 382, 287–291 (2010). https://doi.org/10.1007/s00210-010-0545-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-010-0545-2